A randomized, controlled trial of a multi-modal exercise intervention in Huntington's disease. (October 2016)

• Record Type: Journal Article
• Authors: Quinn, Lori; Hamana, Katy; Kelson, Mark; Dawes, Helen; Collett, Johnny; Townson, Julia; Roos, Raymund; van der Plas, Anton Adriaan; Reilmann, Ralf; Frich, Jan C.; Rickards, Hugh; Rosser, Anne; Busse, Monica
• Is Part Of: Parkinsonism & related disorders. Volume 31(2016)
• Page Start: 46
• Page End: 52
• Publication Date: 2016-10
• Subjects: Huntington's disease -- Exercise -- Rehabilitation -- Aerobic exercise -- Strength training -- Physical therapy; Parkinson's disease -- Periodicals; Movement disorders -- Periodicals; Movement Disorders -- Periodicals; Nerve Degeneration -- Periodicals; Nervous System Diseases -- Periodicals; Parkinson Disease -- Periodicals; Tremor -- Periodicals; Parkinson, Maladie de -- Périodiques; Parkinson's disease; 616.833
• DOI: 10.1016/j.parkreldis.2016.06.023
• Languages: English
• ISSNs: 1353-8020

Abstract

Abstract: Introduction: This study aimed to evaluate the feasibility and benefit of a structured exercise intervention in people with Huntington's Disease (HD). Methods: This study was conducted at 6 sites, and participants were randomized into either exercise or control (usual care) groups, and were assessed at baseline, 13 and 26 weeks. The intervention was a 12 week, three times per week progressive exercise program, including aerobic (stationary cycling) and upper and lower body strengthening exercise with tapered 1:1 support for 20 of 36 sessions. Results: 314 adults were assessed for eligibility: 248 did not meet inclusion criteria, 34 declined, and 32 were recruited and randomized. Three individuals in the intervention group were withdrawn within the first month due to concomitant medical conditions, resulting in 14 participants in intervention and 15 in control groups. There were two AEs in the intervention group, both related to previous medical conditions, and there were two SAEs, both in the control group. The intervention group had better fitness (predicted VO2 max difference: 492.3 ml min −1, 95% CI: [97.1, 887.6]), lower UHDRS mMS (difference 2.9 points, 95% [−5.42, −0.32]) and lower weight at Week 13 (difference 2.25 kg, 95% CI: [−4.47, −0.03]). Conclusion: This study demonstrates that a short-term exercise intervention is safe and feasible. Individuals with HD may benefit from structured exercise, and intensity, monitoring and support may be key factors in optimizing response. Larger scale trials are now required to fully elucidate the extended clinical potential of exercise in HD. Trial registration: Current Controlled Trials ISRCTN11392629. Highlights: A 12-week multi-modal exercise intervention is safe and feasible for people with HD. There was good retention and adherence to the exercise program. Participation in the exercise program led to improved fitness and motor function.